Jabra Enhance Select 200 vs Lucid Ultra 128
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.
Choice

Lucid Ultra 128
The Lucid Ultra 128 is a premium behind-the-ear prescription hearing aid priced at $5,000, earning an A grade with a SoundScore of 4.4/5 in our lab testing. It ranks #17 among 39 prescription hearing aids tested, placing it in the top 41% of its category. Speech performance is where the Lucid Ultra 128 truly excels. In our lab testing, speech in quiet scored a strong 4.3/5, which is 0.95 points above the category average. Speech in noise performance reached 2.7/5, which sits above the category average by 0.59 points, though it remains mixed in absolute terms. This suggests the device handles conversational clarity well in our test scenarios, particularly in quieter environments. The device does face some challenges. Feedback handling scored just 1.7/5, falling 3.02 points below the category average of 4.72/5—a notable weakness compared to other prescription aids in our testing. Music streaming also came in below average at 2.3/5, which is 0.46 points under the category norm. Own-voice comfort scored a mixed 2.9/5, slightly above average. At this price point, several competitors in our database achieved higher overall scores, including the Phonak Sphere Infinio and Oticon Intent. The Lucid Ultra 128 features disposable batteries and supports both iPhone and Android streaming. It may appeal to users who prioritize speech clarity in quiet settings and are less concerned about feedback stability or music streaming fidelity in our standardized tests.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit